BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 12
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (5896)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.
Item 
Count 
PDF535
HTML4905
Figures (1-1)234
Tables (1-2)222
 Sum=5896
Mar 28, 2010 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Takuma Y, Nouso K. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: Our case series and literature review. World J Gastroenterol 2010; 16(12): 1436-1441 [PMID: 20333782 DOI: 10.3748/wjg.v16.i12.1436]
URL: https://www.wjgnet.com/1007-9327/full/v16/i12/1436.htm
Number Citing Articles
1
Brian Shrager, Ghalib A. Jibara, Parissa Tabrizian, Sasan Roayaie, Stephen C. Ward. Resection of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma: A Western Experience. International Journal of Surgical Oncology 2012; 2012: 1 doi: 10.1155/2012/915128
2
Waleed S. Mohamed, Ashraf M. Mostafa, Khaled M. Mohamed, Abdel Hamid Serwah. Effects of fenugreek, Nigella, and termis seeds in nonalcoholic fatty liver in obese diabetic albino rats. Arab Journal of Gastroenterology 2015; 16(1): 1 doi: 10.1016/j.ajg.2014.12.003
3
Hirokazu Kawai, Minoru Nomoto, Takeshi Suda, Kenya Kamimura, Atsunori Tsuchiya, Yasushi Tamura, Masahiko Yano, Masaaki Takamura, Masato Igarashi, Toshifumi Wakai, Satoshi Yamagiwa, Yasunobu Matsuda, Shogo Ohkoshi, Isao Kurosaki, Yoshio Shirai, Masahiko Okada, Yutaka Aoyagi. Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis. World Journal of Hepatology 2011; 3(1): 15-23 doi: 10.4254/wjh.v3.i1.15
4
Monika Pliszka, Leszek Szablewski. Associations between Diabetes Mellitus and Selected Cancers. International Journal of Molecular Sciences 2024; 25(13): 7476 doi: 10.3390/ijms25137476
5
Mazen Noureddin, Mary E. Rinella. Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2): 361 doi: 10.1016/j.cld.2015.01.012
6
Shinichiro Yamada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saito, Mayuko Shimizu, Koichi Tsuneyama, Mitsue Nishiyama, Shiori Ishizawa, Mitsuo Shimada. Effect of daikenchuto (TU-100) on carcinogenesis in non-alcoholic steatohepatitis. The Journal of Medical Investigation 2023; 70(1.2): 66 doi: 10.2152/jmi.70.66
7
Peng Li, Huiguo Ding. Stratified screening of hepatocellular carcinoma in high-risk populations. Radiology of Infectious Diseases 2015; 2(2): 109 doi: 10.1016/j.jrid.2015.07.002
8
Katsutoshi Tokushige, Hideyuki Hyogo, Tomoaki Nakajima, Masafumi Ono, Takumi Kawaguchi, Koichi Honda, Yuichiro Eguchi, Yuichi Nozaki, Miwa Kawanaka, Saiyu Tanaka, Kento Imajo, Yoshio Sumida, Yoshihiro Kamada, Hideki Fujii, Yasuaki Suzuki, Tomomi Kogiso, Yoshiyasu Karino, Kensuke Munekage, Ryoko Kuromatsu, Satoshi Oeda, Mikio Yanase, Kohjiro Mori, Yuji Ogawa, Yuya Seko, Tetsuo Takehara, Yoshito Itoh, Atsushi Nakajima, Kazuyuki Kanemasa, Ken Nishino, Naohiko Masaki, Hirokazu Takahashi, Masataka Seike, Takuji Torimura, Toshiji Saibara, Joji Toyota, Kazuaki Chayama, Etsuko Hashimoto. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey. Journal of Gastroenterology 2016; 51(6): 586 doi: 10.1007/s00535-015-1129-1
9
Sahil Mittal, Donna L. White, Fasiha Kanwal, Norman Sussman, Hashem B. El-Serag. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma: How Common?. Current Hepatology Reports 2015; 14(2): 87 doi: 10.1007/s11901-015-0259-5
10
Centura R. Anbarasu, Sophia Williams-Perez, Ernest R. Camp, Derek J. Erstad. Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. Cancers 2024; 16(16): 2773 doi: 10.3390/cancers16162773
11
Etsuko Hashimoto, Katsutoshi Tokushige. Hepatocellular carcinoma in non‐alcoholic steatohepatitis: Growing evidence of an epidemic?. Hepatology Research 2012; 42(1): 1 doi: 10.1111/j.1872-034X.2011.00872.x
12
Waleed Samy, Mohammed A. Hassanian. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. Arab Journal of Gastroenterology 2011; 12(2): 80 doi: 10.1016/j.ajg.2011.04.008
13
Stephanie Klein, Jean-François Dufour. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Hepatic Oncology 2017; 4(3): 83 doi: 10.2217/hep-2017-0013
14
Omar Massoud, Michael Charlton. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Clinics in Liver Disease 2018; 22(1): 201 doi: 10.1016/j.cld.2017.08.014
15
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142(7): 1592 doi: 10.1053/j.gastro.2012.04.001
16
Ya. M. Vakhrushev, E. V. Suchkova, A. P. Lukashevich. Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2020; 92(2): 29 doi: 10.26442/00403660.2020.02.000400
17
Neeraj Bhala, Jacob George. The Burden of Non-alcoholic Fatty Liver Disease (NAFLD) in the Asia Pacific Region. Current Hepatology Reports 2015; 14(2): 77 doi: 10.1007/s11901-015-0264-8
18
Naoko Ohtani. Chronic Inflammation. 2016; : 187 doi: 10.1007/978-4-431-56068-5_15
19
Isidoro Di Carlo, Maurizio Mannino, Adriana Toro, Annalisa Ardiri, Antonio Galia, Giovanni Cappello, Gaetano Bertino. Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-79
20
Samy L. Habib, Maciej Rojna. Diabetes and Risk of Cancer. ISRN Oncology 2013; 2013: 1 doi: 10.1155/2013/583786
21
Yorinari Ochiai, Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, Yuta Kobayashi, Satoshi Okubo, Nozomu Muraishi, Akira Kajiwara, Soichi Iritani, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Hiromitsu Kumada. Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease. Hepatology Research 2021; 51(1): 62 doi: 10.1111/hepr.13572
22
Takayuki Ozawa, Natsumi Maehara, Toshihiro Kai, Satoko Arai, Toru Miyazaki. Dietary fructose‐induced hepatocellular carcinoma development manifested in mice lacking apoptosis inhibitor of macrophage (AIM). Genes to Cells 2016; 21(12): 1320 doi: 10.1111/gtc.12446
23
Ya M Vakhrushev, E V Suchkova, A P Lukashevich. Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development. Terapevticheskii arkhiv 2019; 91(12): 84 doi: 10.26442/00403660.2019.12.000134
24
Tomo Shimizu, Takashi Sawada, Tomohide Asai, Yuka Kanetsuki, Jiro Hirota, Michihisa Moriguchi, Tomoaki Nakajima, Toru Miyazaki, Takeshi Okanoue. Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM-free AIM. Clinical Journal of Gastroenterology 2022; 15(1): 41 doi: 10.1007/s12328-021-01567-4
25
Mark Benedict, Xuchen Zhang. Non-alcoholic fatty liver disease: An expanded review. World Journal of Hepatology 2017; 9(16): 715-732 doi: 10.4254/wjh.v9.i16.715
26
Yoshitaka Takuma, Kazuhiro Nouso, Yasuhiro Makino, Tomoyuki Gotoh, Nobuyuki Toshikuni, Youichi Morimoto, Hiroyuki Shimomura, Hiroshi Yamamoto. Outcomes after curative treatment for cryptogenic cirrhosis‐associated hepatocellular carcinoma satisfying the Milan criteria. Journal of Gastroenterology and Hepatology 2011; 26(9): 1417 doi: 10.1111/j.1440-1746.2011.06775.x
27
Tze Mun Loo, Fumitaka Kamachi, Yoshihiro Watanabe, Shin Yoshimoto, Hiroaki Kanda, Yuriko Arai, Yaeko Nakajima-Takagi, Atsushi Iwama, Tomoaki Koga, Yukihiko Sugimoto, Takayuki Ozawa, Masaru Nakamura, Miho Kumagai, Koichi Watashi, Makoto M. Taketo, Tomohiro Aoki, Shuh Narumiya, Masanobu Oshima, Makoto Arita, Eiji Hara, Naoko Ohtani. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity. Cancer Discovery 2017; 7(5): 522 doi: 10.1158/2159-8290.CD-16-0932
28
Erin K. Spengler, Rohit Loomba. Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Mayo Clinic Proceedings 2015; 90(9): 1233 doi: 10.1016/j.mayocp.2015.06.013
29
Zenta Walther, Dhanpat Jain. Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance. Pathology Research International 2011; 2011: 1 doi: 10.4061/2011/403929
30
Marcela Salomao, Helen Remotti, Roger Vaughan, Abby B. Siegel, Jay H. Lefkowitch, Roger Klein Moreira. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. Human Pathology 2012; 43(5): 737 doi: 10.1016/j.humpath.2011.07.005
31
Mustafa R. Bashir, Daniela B. Husarik, Tim J. Ziemlewicz, Rajan T. Gupta, Daniel T. Boll, Elmar M. Merkle. Liver MRI in the hepatocyte phase with gadolinium‐EOB‐DTPA: Does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?. Journal of Magnetic Resonance Imaging 2012; 35(3): 611 doi: 10.1002/jmri.22850
32
Shivakumar Chitturi, Vincent Wai‐Sun Wong, Geoff Farrell. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. Journal of Gastroenterology and Hepatology 2011; 26(s1): 163 doi: 10.1111/j.1440-1746.2010.06548.x
33
Iliana Doycheva, Niraj Patel, Michael Peterson, Rohit Loomba. Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. Journal of Diabetes and its Complications 2013; 27(3): 293 doi: 10.1016/j.jdiacomp.2012.10.008
34
Heinz Zoller, Herbert Tilg. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Metabolism 2016; 65(8): 1151 doi: 10.1016/j.metabol.2016.01.010
35
Xiao-Yan Duan, Lei Zhang, Jian-Gao Fan, Liang Qiao. NAFLD leads to liver cancer: Do we have sufficient evidence?. Cancer Letters 2014; 345(2): 230 doi: 10.1016/j.canlet.2013.07.033
36
Ali Zarrinpar, Claire M. Faltermeier, Vatche G. Agopian, Bita V. Naini, Michael P. Harlander‐Locke, Fady M. Kaldas, Douglas G. Farmer, Ronald W. Busuttil. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis. Liver International 2019; 39(3): 531 doi: 10.1111/liv.14002
37
Narayan Dharel, Daryl T. Lau. Primary Liver Cancer. 2012; : 229 doi: 10.1007/978-1-61779-863-4_12
38
Naile Bolca Topal, Serap Orcan, Deniz Sığırlı, Gökhan Orcan, Ülkü Eritmen. Effects of fat accumulation in the liver on hemodynamic variables assessed by doppler ultrasonography. Journal of Clinical Ultrasound 2015; 43(1): 26 doi: 10.1002/jcu.22157
39
Swastik Agrawal, Ajay K Duseja. Non-alcoholic Fatty Liver Disease: East Versus West. Journal of Clinical and Experimental Hepatology 2012; 2(2): 122 doi: 10.1016/S0973-6883(12)60101-7
40
Naoko Ohtani, Norifumi Kawada. Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship. Hepatology Communications 2019; 3(4): 456 doi: 10.1002/hep4.1331
41
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55(6): 2005 doi: 10.1002/hep.25762
42
Shin Yoshimoto, Tze Mun Loo, Koji Atarashi, Hiroaki Kanda, Seidai Sato, Seiichi Oyadomari, Yoichiro Iwakura, Kenshiro Oshima, Hidetoshi Morita, Masahira Hattori, Kenya Honda, Yuichi Ishikawa, Eiji Hara, Naoko Ohtani. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499(7456): 97 doi: 10.1038/nature12347
43
Kazuki Takakura, Tsunekazu Oikawa, Masanori Nakano, Chisato Saeki, Yuichi Torisu, Mikio Kajihara, Masayuki Saruta. Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00762
44
Xiao-Yan Duan, Liang Qiao, Jian-Gao Fan. Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2012; 11(1): 18 doi: 10.1016/S1499-3872(11)60120-3
45
Kishore Polireddy, Hemantkumar Chavan, Bashar A. Abdulkarim, Partha Krishnamurthy. Functional significance of the ATP‐binding cassette transporter B6 in hepatocellular carcinoma. Molecular Oncology 2011; 5(5): 410 doi: 10.1016/j.molonc.2011.07.005
46
Hsuan Yeh, Chun-Cheng Chiang, Tzung-Hai Yen. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World Journal of Gastroenterology 2021; 27(26): 4104-4142 doi: 10.3748/wjg.v27.i26.4104
47
Zhen-Feng Wu, Zhe Xu, Wei-Su Li, Hai-Bin Zhang, Ning Yang, Xue-Quan Yao, Fu-Kun Liu, Guang-Shun Yang. Impact of occult hepatitis B virus infection on outcome after resection for non-B non-C hepatocellular carcinoma. Journal of Surgical Research 2015; 193(1): 153 doi: 10.1016/j.jss.2014.07.021
48
Ryo Takuma, Toshiya Morozumi, Yuko Yamamoto, Takashi Kobayashi, Takaaki Matsui, Masato Yoneda, Takaomi Kessoku, Asako Nogami, Muneaki Tamura, Yohei Kamata, Shuntaro Sugihara, Yoshiaki Nomura, Masahiro To, Masato Minabe, Kenji Mitsudo, Atsushi Nakajima, Motohiro Komaki. Association between Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma and Periodontopathic Bacteria: A Cross-Sectional Pilot Study. Applied Sciences 2023; 13(6): 3893 doi: 10.3390/app13063893
49
Yan Guo, Yanhua Xiong, Quanghu Sheng, Shilin Zhao, Julia Wattacheril, Charles Robb Flynn. A micro-RNA expression signature for human NAFLD progression. Journal of Gastroenterology 2016; 51(10): 1022 doi: 10.1007/s00535-016-1178-0
50
Michael Kram. Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis. World Journal of Hepatology 2023; 15(2): 201-207 doi: 10.4254/wjh.v15.i2.201
51
A V Tkachev, G N Tarasova, V S Groshilin, D A Vasilchenkov, T I Ushakova, D V Blinov. Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study. Terapevticheskii arkhiv 2016; 88(8): 59 doi: 10.17116/terarkh201688859-66
52
Sean N. O’Byrne, John W. Scott, Joseph R. Pilotte, André da S. Santiago, Christopher G. Langendorf, Jonathan S. Oakhill, Benjamin J. Eduful, Rafael M. Couñago, Carrow I. Wells, William J. Zuercher, Timothy M. Willson, David H. Drewry. In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds. Molecules 2020; 25(2): 325 doi: 10.3390/molecules25020325
53
Lorenzo A. Orci, Marco Sanduzzi-Zamparelli, Berta Caballol, Victor Sapena, Nicola Colucci, Ferran Torres, Jordi Bruix, María Reig, Christian Toso. Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression. Clinical Gastroenterology and Hepatology 2022; 20(2): 283 doi: 10.1016/j.cgh.2021.05.002
54
Robert J Wong, Aijaz Ahmed. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World Journal of Hepatology 2014; 6(5): 263-273 doi: 10.4254/wjh.v6.i5.263
55
Benjamin J. Eduful, Sean N. O’Byrne, Louisa Temme, Christopher R. M. Asquith, Yi Liang, Alfredo Picado, Joseph R. Pilotte, Mohammad Anwar Hossain, Carrow I. Wells, William J. Zuercher, Carolina M. C. Catta-Preta, Priscila Zonzini Ramos, André de S. Santiago, Rafael M. Couñago, Christopher G. Langendorf, Kévin Nay, Jonathan S. Oakhill, Thomas L. Pulliam, Chenchu Lin, Dominik Awad, Timothy M. Willson, Daniel E. Frigo, John W. Scott, David H. Drewry. Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes. Journal of Medicinal Chemistry 2021; 64(15): 10849 doi: 10.1021/acs.jmedchem.0c02274
56
HIROKI NISHIKAWA, YUKIO OSAKI. Non-B, non-C hepatocellular carcinoma. International Journal of Oncology 2013; 43(5): 1333 doi: 10.3892/ijo.2013.2061
57
Ryan B Perumpail, Andy Liu, Robert J Wong, Aijaz Ahmed, Stephen A Harrison. Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. World Journal of Hepatology 2015; 7(22): 2384-2388 doi: 10.4254/wjh.v7.i22.2384
58
Ramesh Kumar, Rajeev Nayan Priyadarshi, Utpal Anand. Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00051
59
I. I. Zhirkov, A. V. Gordienko, N. I. Gulyaev, D. Yu. Serdyukov, A. A. Stepanova. Chronic diffuse liver disease of non-viral etiology in the military. Bulletin of the Russian Military Medical Academy 2019; 21(4): 72 doi: 10.17816/brmma20668
60
Natsumi Maehara, Satoko Arai, Mayumi Mori, Yoshihiro Iwamura, Jun Kurokawa, Toshihiro Kai, Shunsuke Kusunoki, Kaori Taniguchi, Kazutaka Ikeda, Osamu Ohara, Ken-ichi Yamamura, Toru Miyazaki. Circulating AIM Prevents Hepatocellular Carcinoma through Complement Activation. Cell Reports 2014; 9(1): 61 doi: 10.1016/j.celrep.2014.08.058
61
Naoko Ohtani. Microbiome and cancer. Seminars in Immunopathology 2015; 37(1): 65 doi: 10.1007/s00281-014-0457-1
62
Tomoko Yamazaki, Mayumi Mori, Satoko Arai, Ryosuke Tateishi, Masanori Abe, Mihoko Ban, Akemi Nishijima, Maki Maeda, Takeharu Asano, Toshihiro Kai, Kiyohiro Izumino, Jun Takahashi, Kayo Aoyama, Sei Harada, Toru Takebayashi, Toshiaki Gunji, Shin Ohnishi, Shinji Seto, Yukio Yoshida, Yoichi Hiasa, Kazuhiko Koike, Ken-ichi Yamamura, Ken-ichiro Inoue, Toru Miyazaki, Kalpana Ghoshal. Circulating AIM as an Indicator of Liver Damage and Hepatocellular Carcinoma in Humans. PLoS ONE 2014; 9(10): e109123 doi: 10.1371/journal.pone.0109123
63
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
64
Hiromi Kan, Sho‐ichi Yamagishi, Ayako Ojima, Kei Fukami, Seiji Ueda, Masayoshi Takeuchi, Hideyuki Hyogo, Hiroshi Aikata, Kazuaki Chayama. Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non‐B or Non‐C Hepatocellular Carcinoma. Journal of Clinical Laboratory Analysis 2015; 29(6): 480 doi: 10.1002/jcla.21797
65
Chie Yokouchi, Yukari Nishimura, Hirohiko Goto, Makoto Sato, Yuya Hidoh, Kenji Takeuchi, Yuji Ishii. Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase. The Journal of Toxicological Sciences 2021; 46(1): 31 doi: 10.2131/jts.46.31
66
Sene Waly Raphael, Zhang Yangde, Chen YuXiang. Hepatocellular Carcinoma: Focus on Different Aspects of Management. ISRN Oncology 2012; 2012: 1 doi: 10.5402/2012/421673
67
Waleed Samy Mohamed. Metabolic Effects of Foenugreek, Nigella and Termis: Review Article. International Journal of Pharmacology, Phytochemistry and Ethnomedicine 2016; 3: 90 doi: 10.18052/www.scipress.com/IJPPE.3.90
68
Mary Maluccio, Anne Covey. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA: A Cancer Journal for Clinicians 2012; 62(6): 394 doi: 10.3322/caac.21161
69
Manon Allaire, Benoit Dupont, Pierre Nahon, Nathalie Ganne-Carrié, Jean Charles Nault. Hepatocellular Carcinoma: the Impact of NAFLD. Current Hepatology Reports 2016; 15(3): 190 doi: 10.1007/s11901-016-0303-0
70
Jun-ichi Takino, Kentaro Nagamine, Takamitsu Hori, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma. World Journal of Hepatology 2015; 7(23): 2459-2469 doi: 10.4254/wjh.v7.i23.2459
71
C. Bunchorntavakul, R. Bahirwani, D. Drazek, M. C. Soulen, E. S. Siegelman, E. E. Furth, K. Olthoff, A. Shaked, K. R. Reddy. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Alimentary Pharmacology & Therapeutics 2011; 34(6): 664 doi: 10.1111/j.1365-2036.2011.04772.x
72
Ayse L. Mindikoglu, Antone R. Opekun, Sood K. Gagan, Sridevi Devaraj. Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/3932491
73
György Baffy, Elizabeth M. Brunt, Stephen H. Caldwell. Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace. Journal of Hepatology 2012; 56(6): 1384 doi: 10.1016/j.jhep.2011.10.027
74
Donna L. White, Fasiha Kanwal, Hashem B. El–Serag. Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review. Clinical Gastroenterology and Hepatology 2012; 10(12): 1342 doi: 10.1016/j.cgh.2012.10.001
75
Ramesh Kumar. Hard clinical outcomes in patients with NAFLD. Hepatology International 2013; 7(S2): 790 doi: 10.1007/s12072-013-9455-y
76
Luis Calzadilla Bertot, Leon A Adams. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019; 13(2): 179 doi: 10.1080/17474124.2019.1549989
77
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
78
Paola Dongiovanni, Stefano Romeo, Luca Valenti. Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors. World Journal of Gastroenterology 2014; 20(36): 12945-12955 doi: 10.3748/wjg.v20.i36.12945
79
F. Cauchy, D. Fuks, J. Belghiti. HCC: current surgical treatment concepts. Langenbeck's Archives of Surgery 2012; 397(5): 681 doi: 10.1007/s00423-012-0911-2
80
Óscar Núñez Martínez, Ana Matilla Peña, Beatriz Merino Rodríguez, Antonio Díaz Sánchez, Arturo Colón Rodríguez, Enrique Ramón Botella, Ismael Yepes Barreto, Marisa Prieto Martín, José María Tellado Rodríguez, Gerardo Clemente Ricote. Estudio descriptivo de la experiencia sobre carcinoma hepatocelular en hígado no cirrótico. Gastroenterología y Hepatología 2011; 34(5): 322 doi: 10.1016/j.gastrohep.2011.02.002
81
Annabelle L. Fonseca, Charles H. Cha. Hepatocellular carcinoma: A comprehensive overview of surgical therapy. Journal of Surgical Oncology 2014; 110(6): 712 doi: 10.1002/jso.23673
82
Toshifumi Wakai, Yoshio Shirai, Jun Sakata, Pavel Vladimirovich Korita, Yoichi Ajioka, Katsuyoshi Hatakeyama. Surgical Outcomes for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Journal of Gastrointestinal Surgery 2011; 15(8): 1450 doi: 10.1007/s11605-011-1540-8
83
Tomi W. Jun, Ming‐Lun Yeh, Ju Dong Yang, Vincent L. Chen, Pauline Nguyen, Nasra H. Giama, Chung‐Feng Huang, Ann W. Hsing, Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang, Lewis R. Roberts, Ming‐Lung Yu, Mindie H. Nguyen. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma. Liver International 2018; 38(5): 895 doi: 10.1111/liv.13613
84
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
85
George Boon-Bee Goh, Pik-Eu Chang, Chee-Kiat Tan. Changing epidemiology of hepatocellular carcinoma in Asia. Best Practice & Research Clinical Gastroenterology 2015; 29(6): 919 doi: 10.1016/j.bpg.2015.09.007
86
Kristin S. Bramlage, Vivek Bansal, Stavra A. Xanthakos, Rohit Kohli. Fatty Liver Disease in Children—What Should One Do?. The Indian Journal of Pediatrics 2013; 80(S1): 109 doi: 10.1007/s12098-012-0826-5
87
Patrícia Lofêgo Gonçalves, Maria da Penha Zago-Gomes, Carlos Sandoval Gonçalves, Fausto Edmundo Lima Pereira. Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Espírito Santo. Revista da Sociedade Brasileira de Medicina Tropical 2014; 47(5): 559 doi: 10.1590/0037-8682-0145-2014
88
G. Vernon, A. Baranova, Z. M. Younossi. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics 2011; 34(3): 274 doi: 10.1111/j.1365-2036.2011.04724.x
89
Malcolm H. Squires, David A. Kooby. Surgical Oncology. 2015; : 335 doi: 10.1007/978-1-4939-1423-4_15
90
Bou-Zenn Lin, Tsung-Jung Lin, Chih-Lin Lin, Li-Ying Liao, Ting-An Chang, Buo-Jia Lu, Kuan-Yang Chen. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. Journal of the Chinese Medical Association 2021; 84(6): 606 doi: 10.1097/JCMA.0000000000000530
91
Marc Connelly, Michael G. Bruce, Lisa Bulkow, Mary Snowball, Brian J. McMahon. The changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people. Liver International 2016; 36(12): 1829 doi: 10.1111/liv.13173
92
Ajay Duseja, Naga Chalasani. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD). Hepatology International 2013; 7(S2): 755 doi: 10.1007/s12072-013-9480-x
93
Krzysztof Lukasz Kopec, David Burns. Nonalcoholic Fatty Liver Disease. Nutrition in Clinical Practice 2011; 26(5): 565 doi: 10.1177/0884533611419668
94
Marcus Grohmann, Florian Wiede, Garron T. Dodd, Esteban N. Gurzov, Geraldine J. Ooi, Tariq Butt, Aliki A. Rasmiena, Supreet Kaur, Twishi Gulati, Pei K. Goh, Aislinn E. Treloar, Stuart Archer, Wendy A. Brown, Mathias Muller, Matthew J. Watt, Osamu Ohara, Catriona A. McLean, Tony Tiganis. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell 2018; 175(5): 1289 doi: 10.1016/j.cell.2018.09.053
95
Naga Chalasani, Zobair Younossi, Joel E Lavine, Anna Mae Diehl, Elizabeth M Brunt, Kenneth Cusi, Michael Charlton, Arun J Sanyal. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. American Journal of Gastroenterology 2012; 107(6): 811 doi: 10.1038/ajg.2012.128
96
Jacob Alexander, Michael Torbenson, Tsung‐Teh Wu, Matthew M. Yeh. Non‐alcoholic fatty liver disease contributes to hepatocarcinogenesis in non‐cirrhotic liver: A clinical and pathological study. Journal of Gastroenterology and Hepatology 2013; 28(5): 848 doi: 10.1111/jgh.12116
97
Robert J. Wong, Ramsey Cheung, Aijaz Ahmed. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.. Hepatology 2014; 59(6): 2188 doi: 10.1002/hep.26986
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345